AP NEWS

2 Day Conference: Neuroscience R&D Technologies (Munich, Germany - October 4-5, 2018) - ResearchAndMarkets.com

August 21, 2018

DUBLIN--(BUSINESS WIRE)--Aug 21, 2018--The “Neuroscience R&D Technoligies” conference has been added to ResearchAndMarkets.com’s offering.

This conference will focus on discussing the latest technologies in the preclinical, translational neuroscience space and also drawing the attention of the audience towards new innovations happening in translational neuroscience imaging.

The conference further aims bringing in the experts from academia and industry together to discuss how to create new, more effective translational neuroscience drawing on novel technology and recent discoveries.

There will be live case studies, keynote presentations and breakthrough panel discussion sessions during the two-day meet.

Neuroscience research continues to evolve in order to cope up with changing industry dynamics. Recent strategic partnerships and mergers have not only experienced R&D cuts but also shut down of entire R&D sites. As a result, industry is now more keen on investing in biotechnology start-ups to build their new pipeline for neuro products.

Discovering medicines to treat neurodegenerative disorders like Alzheimer’s, Parkinson’s and Dementia has been extremely challenging in the past decades. But through recent advances in stem cell technology, functional neuroimaging, better animal models, neuromodulation and deep brain stimulation; scientific understanding and expectations are now gathering pace.

Why Attend?

First ever conference on application of technology in developing neurological treatments Meet global heads of neuroscience from the industry and Academics 100+ neuroscience professionals attending Access to online presentations on-demand post-summit Case studies presented from leading technology collaborations Interactive panel and breakout sessions

Agenda Topics

Human IPSC and Blood Brain Barrier Pre-clinical/Translational developments in CNS Functional Neuroimaging Technologies Optogenetics in brain mapping Animal Models and mechanisms Disease modeling and drug discovery Deep brain stimulation and neuromodulation

For more information about this conference visit https://www.researchandmarkets.com/research/zr62pq/2_day_conference?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180821005580/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/21/2018 01:22 PM/DISC: 08/21/2018 01:22 PM

http://www.businesswire.com/news/home/20180821005580/en

AP RADIO
Update hourly